Search
Cardiolipin Biosynthesis CL(a-13:0/a-21:0/22:0/22:0)
smpdb.ca/view/SMP0369336MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-13:0/a-21:0/22:0/24:0)
smpdb.ca/view/SMP0369338MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-13:0/a-21:0/22:0/25:0)
smpdb.ca/view/SMP0369339MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-13:0/a-21:0/23:0/24:0)
smpdb.ca/view/SMP0369344MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-13:0/a-21:0/23:0/25:0)
smpdb.ca/view/SMP0369345MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-15:0/a-21:0/24:0/25:0)
smpdb.ca/view/SMP0369684MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Tramadol
go.drugbank.com/drugs/DB00193ApprovedInvestigationalIt is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of [morphine]. … [A4269,A183842] Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators.
Mixtures: Ag-acet-tramadol, DOR-2®Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesCyclosporin A Action Pathway
smpdb.ca/view/SMP0124614Drug actionCyclosporin A is a calcineurin inhibitor that is most often used as an immunosuppressive drug for organ transplant patients in order to reduce the activity of the immune system lowering the risk of organ … Cyclosporin A is administered orally, intravenously or through a topical treatment which allows the drug to be absorbed into the bloodstream.
Drugs: CalciumEnzymes: Peptidyl-prolyl cis-trans isomerase ADe Novo Triacylglycerol Biosynthesis TG(10:0/a-13:0/a-15:0)
smpdb.ca/view/SMP0031935MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. … Last, the enzyme diacylglycerol O-acyltransferase synthesizes triacylglycerol from diacylglycerol and a fatty acyl-CoA.
De Novo Triacylglycerol Biosynthesis TG(10:0/a-15:0/a-13:0)
smpdb.ca/view/SMP0031963MetabolicA triglyceride (TG, triacylglycerol, TAG, or triacylglyceride) is an ester derived from glycerol and three fatty acids. … Last, the enzyme diacylglycerol O-acyltransferase synthesizes triacylglycerol from diacylglycerol and a fatty acyl-CoA.